WallStSmart

PetMed Express Inc (PETS)vsPOMDOCTOR LIMITED American Depositary Shares (POM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

POMDOCTOR LIMITED American Depositary Shares generates 96% more annual revenue ($366.86M vs $186.96M). PETS leads profitability with a -34.7% profit margin vs -40.6%. PETS earns a higher WallStSmart Score of 43/100 (D).

PETS

Hold

43

out of 100

Grade: D

Growth: 2.7Profit: 2.0Value: 6.7Quality: 5.0

POM

Avoid

28

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -66.56

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PETS1 strengths · Avg: 8.0/10
Price/BookValuation
1.5x8/10

Reasonable price relative to book value

POM2 strengths · Avg: 9.0/10
Debt/EquityHealth
-0.1910/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
16.2%8/10

16.2% revenue growth

Areas to Watch

PETS4 concerns · Avg: 3.3/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Market CapQuality
$49.22M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-100.6%2/10

ROE of -100.6% — below average capital efficiency

POM4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$40.13M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-16.17M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : PETS

The strongest argument for PETS centers on Price/Book.

Bull Case : POM

The strongest argument for POM centers on Debt/Equity, Revenue Growth. Revenue growth of 16.2% demonstrates continued momentum.

Bear Case : PETS

The primary concerns for PETS are PEG Ratio, EPS Growth, Market Cap.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

PETS profiles as a turnaround stock while POM is a growth play — different risk/reward profiles.

POM is growing revenue faster at 16.2% — sustainability is the question.

PETS generates stronger free cash flow (-10M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PETS scores higher overall (43/100 vs 28/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PetMed Express Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Want to dig deeper into these stocks?